Roles of factor XI, platelets and tissue factor-initiated blood coagulation

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 10, 2003, Pages 2081-2086

  Walsh, P N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; PHOSPHOLIPID; THROMBOPLASTIN;

BIOLOGICAL MODEL; BLOOD CLOTTING; HUMAN; METABOLISM; NOTE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; THROMBOCYTE; THROMBOCYTE ACTIVATION;

BLOOD COAGULATION; BLOOD PLATELETS; FACTOR XI; HUMANS; MODELS, BIOLOGICAL; PHOSPHOLIPIDS; PLATELET ACTIVATION; PROTEIN STRUCTURE, TERTIARY; THROMBOPLASTIN;

EID: 1842840779     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00460.x     Document Type: Article

References (82)

1. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964; 145: 1310-2.
2. MacFarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964; 202: 498-9.
3. Colman RW. Contact activation pathway: inflammatory, fibrinolytic, anticoagulant, antiadhesive and antiangiogenic activities. In: Colman, RW, Hirsh, J, Marder, VJ, Clowes, AW, George, JN, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, Chapter 6,4th edn. Philadelphia: Lippincott Williams & Wilkins, 2001: 103-22.
4. Morrissey JH. Tissue factor and factor VII initiation of coagulation. In: Colman, RW, Hirsh, J, Marder, VJ, Clowes, AW, George, JN, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, Chapter 5,4th edn. Philadelphia: Lippincott Williams & Wilkins, 2001: 89-102.
5. Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325: 153-8.
6. Bolton-Maggs PH, Young Wan-Yin B, McCraw AH, Slack J, Kernoff PB. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988; 69: 521-8.
7. Hu CJBaglia FA, Mills DC, Konkle BA, Walsh PN. Tissue-specific expression of functional platelet factor XI is independent of plasma factor XI expression. Blood 1998; 91: 3800-7.
8. Leiba H, Ramot B, Many A. Hereditary and coagulation studies in ten families with factor XI (plasma thromboplastin antecedent) deiciency. Br J Haematol 1965; 11: 654-65.
9. Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood 1985; 65: 719-24.
10. Rapaport SI, Proctor RR, Patch MJ, Yettra M. The mode of inheritance of PTA deficiency: evidence for the existence of a major PTA deficiency and a minor PTA deficiency. Blood 1961; 18: 149-55.
11. Rosenthal RL, Dreskin OH, Rosenthal N. New hemophilia-like disease caused by deiciency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med 1953; 82: 171-4.
12. Sidi A, Seligsohn U, Jonas P, Many M. Factor XI deiciency. detection and management during urologic surgery. J Urol 1978; 119: 528-30.
13. Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 1991; 266: 7353-8.
14. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-12.
15. Baglia FA, Jameson BA, Walsh PN. Identification and characterization of a binding site for platelets in the Apple 3 domain of coagulation factor XI. J Biol Chem 1995; 270: 6734-40.
16. Greengard JS, Heeb MJ, Ersdal E, Walsh PN, Griffin JH. Binding of coagulation factor XI to washed human platelets. Biochemistry 1986; 25: 3884-90.
17. Ho DH, Baglia FA, Walsh PN. Factor XI binding to activated platelets is mediated by residues R (250), K (255), F (260), and Q (263) within the Apple 3 domain. Biochemistry 2000; 39: 316-23.
18. Baglia FA, Walsh PN. Prothrombin is a cofactor for the binding offactor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin. Biochemistry 1998; 37: 2271-81.
19. Baglia FA, Walsh PN. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. J Biol Chem 2000; 275: 20514-9.
20. Baglia FA, Badellino KO, Li CQ, Lopez JA, Walsh PN. Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin. J Biol Chem 2002; 277: 1662-8.
21. Baglia FA, Shrimpton CN, Lopez JA, Walsh PN. The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane. J Biol Chem 2003; 278: 21744-50.
22. Broze GJJ, Miletich JP. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci USA 1987; 84: 1886-90.
23. Broze GJJ, Miletich JP. Characterization of the inhibition of tissue factor in serum. Blood 1987; 69: 150-5.
24. Hubbard AR, Jennings CA. Inhibition of tissue thromboplastin-mediated blood coagulation. Thromb Res 1986; 42: 489-98.
25. Hubbard AR, Jennings CA. Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins. Thromb Res 1987; 46: 527-37.
26. Morrison SA, Jesty J. Tissue factor-dependent activation of tritium labeled factor IX and factor X in human plasma. Blood 1984; 63: 1338-47.
27. Rao LVM, Rapaport SI. Studies on the mechanisms ofinactivation ofthe extrinsic pathway of coagulation. Blood 1987; 69: 645-51.
28. Sanders NL, Bajaj SP, Zivelin A, Rapaport SI. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood 1985; 66: 204-12.
29. Anson DS, Choo KH, Rees DJ, Giannelli F, Gould K, Huddleston JA, Brownlee GG. The gene structure of human anti-haemophilic factor IX. Embo J 1984; 3: 1053-60.
30. Di Scipio RG, Kurachi K, Davie EW. Activation of human factor IX (Christmas factor). J Clin Invest 1978; 61: 1528-38.
31. Fujikawa K, Legaz ME, Kato H, Davie EW. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent). Biochemistry 1974; 13: 4508-16.
32. Jagadeeswaran P, Lavelle DE, Kaul R, Mohandas T, Warren ST. Isolation and characterization of human factor IX cDNA: identiication of Taq I polymorphism and regional assignment. Somat Cell Mol Genet 1984; 10: 465-73.
33. Jaye M, de la Salle H, Schamber F, Balland A, Kohli V, Findeli A, Tolstoshev P, Lecocq JP. Isolation of a human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX. Nucl Acids Res 1983; 11: 2325-35.
34. Kurachi K, Davie EW. Isolation and characterization of a cDNA coding for human factor IX. Proc Natl Acad Sci USA 1982; 79: 6461-4.
35. Österud B, Bouma BN, Griffin JH. Human blood coagulation factor IX. Puriication, properties, and mechanism of activation by activated factor XI. J Biol Chem 1978; 253: 5946-51.
36. Sinha D, Seaman FS, Walsh PN. Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX. Biochemistry 1987; 26: 3768-75.
37. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 1985; 24: 3736-50.
38. Österud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-4.
39. Jesty J, Silverberg SA. Kinetics of the tissue factor-dependent activation of coagulation factors IX and X in a bovine plasma system. J Biol Chem 1979; 254: 12337-45.
40. Walsh PN, Bradford H, Sinha D, Piperno JR, Tuszynski GP. Kinetics of the factor XIa catalyzed activation of human blood coagulation factor IX. J Clin Invest 1984; 73: 1392-9.
41. Zur M, Nemerson Y. Kinetics of factor IX activation via the extrinsic pathway dependence of Km on tissue factor. J Biol Chem 1980; 255: 5703-7.
42. Cawthern KM, van't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood 1998; 91: 4581-92.
43. He R, Xiong S, He X, Liu F, Han J, Li J, He S. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway. Thromb Haemost 2001; 85: 1055-9.
44. Keularts IM, Zivelin A, Seligsohn U, Hemker HC, Beguin S. The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost 2001; 85: 1060-5.
45. Butenas S, van't Veer C, Mann KG. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. JBiol Chem 1997; 272: 21527-33.
46. Butenas S, van't Veer C, Mann KG. 'Normal' thrombin generation. Blood 1999; 94: 2169-78.
47. London FS, Walsh PN. Zymogen factor IX potentiates factor IXa-catalyzed factor X activation. Biochemistry 2000; 39: 9850-8.
48. Oliver JA, Monroe DM, Roberts HR, Hoffman M. Thrombin activates factorXI on activated platelets in the absence offactorXII. Arterioscler Thromb Vasc Biol 1999; 19: 170-7.
49. Hoffman M, Monroe DM, Oliver JA, Roberts HR. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995; 86: 1794-801.
50. von dem Borne PA, Meijers JC, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects ibrin clots from ibrinolysis. Blood 1995; 86: 3035-42.
51. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activatable ibrinolysis inhibitor. J Biol Chem 1995; 270: 14477-84.
52. Hendriks D, Scharpe S, Van Sande M, Lommaert MP. Characterization of a carboxypeptidase in human serum distinct from carboxypeptidase. Clin Chem Clin Biochem 1989; 27: 277-85.
53. Redlitz A, Tan AK, Eaton DL, Plow EF. Plasma carboxypeptidases as regulators of the plasminogen system. J Clin Invest 1995; 96: 2534-8.
54. Tan AK, Eaton DL. Activation and characterization of procarboxypep-tidase B from human plasma. Biochemistry 1995; 34: 5811-6.
55. Wang W, Hendriks D, Scharpe S. Carboxypeptidase U: a plasma carboxypeptidase with high afinity for plasminogen. J Biol Chem 1994; 269: 15937-44.
56. Komiyama Y, Nomura S, Murakami T, Masuda M, Egawa H, Murata K, Okubo S, Kokawa T, Yasunaga K. Puriication and characterization of platelet-type factor XI from human platelets. Thromb Haemost 1993; 69: 1238 [Abstract].
57. Schiffman S, Rapaport SI, Chong MM. Platelets and initiation of intrinsic clotting. Br J Haematol 1973; 24: 633-42.
58. Schiffman S, Yeh CH. Puriication and characterization ofplateletfactor XI. Thromb Res 1990; 60: 87-97.
59. Tuszynski GP, Bevacqua SJ, Schmaier AH, Colman RW, Walsh PN. Factor XI antigen and activity in human platelets. Blood 1982; 59: 1148-56.
60. Lipscomb MS, Walsh PN. Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI. J Clin Invest 1979; 63: 1006-14.
61. Hsu TC, Shore SK, Seshsmma T, Bagasra O, Walsh PN. Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI gene. J Biol Chem 1998; 273: 13787-93.
62. Martincic D, Kravtsov V, Gailani D. Factor XI messenger RNA in human platelets. Blood 1999; 94: 3397-404.
63. Rimon A, Schiffman S, Feinstein DI, Rapaport SI. Factor XI activity and factor XI antigen in homozygous and heterozygous factor XI deficiency. Blood 1976; 48: 165-74.
64. Rosenthal RL, Dreskin OH, Rosenthal N. Plasma thromboplastin antecedent (PTA) deficiency. Clinical coagulation, therapeutic and hereditary aspects of a new hemophilia-like disease. Blood 1955; 10: 120-31.
65. Griffin JH, Cochrane CG. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proc Natl Acad Sci USA 1976; 73: 2554-8.
66. Meier HL, Pierce JV, Colman RW, Kaplan AP. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest 1977; 60: 18-31.
67. Ratnoff OD, Davie EW, Mallett DL. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest 1961; 40: 803-19.
68. Thompson RE, Mandle R Jr, Kaplan AP. Association of factor XI, high molecular weight kininogen in human plasma. J Clin Invest 1977; 60: 1376-80.
69. Wiggins RC, Bouma BN, Cochrane CG, Grifin JH. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation factor XI and prekallikrein. Proc Natl Acad Sci USA 1977; 74: 4636-40.
70. Liu CY, Scott CF, Bagdasarian A, Pierce JV, Kaplan AP, Colman RW. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen. J Clin Invest 1977; 60: 7-17.
71. Saito H, Ratnoff OD, Marshall JS, Pensky J. Partial puriication of plasma thromboplastin antecedent (factor XI) and its activation by trypsin. J Clin Invest 1973; 52: 850-61.
72. Schiffman S, Lee P. Preparation, characterization, and activation of a highly puriied factor XI: evidence that a hitherto unrecognized plasma activity participates in the interaction of factors XI and XII. Br J Haematol 1974; 27: 101-14.
73. Schiffman S, Markland FS Jr. Effect of intermediates of extrinsic clotting on purified factor XI: factor VII and/or thromboplastin. Thromb Res 1975; 6: 273-9.
74. Bouma BN, Grifin JH. Human blood coagulation factor XI. Puriication, properties, and mechanism of activation by activated factor XII. J Biol Chem 1977; 252: 6432-7.
75. Kurachi K, Davie EW. Activation of human factor XI (plasma throm-boplastin antecedent) by factor XIIa (activated Hageman factor). Biochemistry 1977; 16: 5831-9.
76. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time invivo imaging of platelets, tissue factor and ibrin during arterial thrombus formation in the mouse. Nat Med 2002; 8: 1175-81.
77. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
78. Himber J, Kling D, Fallon JT, Nemerson Y, Riederer MA. In situ localization of tissue factor in human thrombi. Blood 2002; 99: 4249-50.
79. Morrissey JH. Tissue factor: in at the start... and the finish? J Thromb Haemost 2003; 1: 878-80.
80. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000; 96: 170-5.
81. Rauch U, Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med 2000; 10: 139-43.
82. Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue factor-bearing microparticles arise from monocyte lipid rafts and can fuse with activated platelets, consolidating all of the membrane-bound coagulation reactions on the platelet surface. J Thromb Haemost 2003; 1 (Suppl. 1): Abstract OC146.